Avella Selected by Pfizer to Distribute Ibrance
February 9th 2015Avella Specialty Pharmacy announced today that it has been selected by Pfizer as one of the limited groups of specialty pharmacies authorized to distribute the manufacturer's breakthrough breast cancer drug-Ibrance (palbociclib)-which has just received fast-tracked approval from the FDA.
Read More
Pharmacy Development Services (PDS), the leading provider of business education for independent pharmacy owners, has announced the ten recipients of the 2015 PDS Conference Showcase of Success. For the past nine years, the Showcase of Success segment has been an integral part of the annual business growth conference as a way to demonstrate the opportunities for real results in the industry.
Read More
Avella Selected by GlaxoSmithKline to Retain Access to Benlysta
February 5th 2015Avella Specialty Pharmacy announced today that it has been selected by GlaxoSmithKline as one of a select group of pharmacies authorized to continue to distribute Benlysta, a medication approved by the FDA for the treatment of systemic lupus erythematosus in patients who have previously received other therapies.
Read More